Value of electrophysiology in the follow-up of dysimmune polyneuropathies;Intérêt de l'électrophysiologie dans le suivi d'une polyneuropathie dysimmunitaire

Revue Medicale de Liege

Volumn 59, Issue SUPPL. 1, 2004, Pages 124-132

  Leger J M ^a,b  

^a GNPS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CIDP; Dysimmune polyneuropathies; Electrophysiological studies; Monoclonal gammopathy; Multifocal motor neuropathy

Indexed keywords

AMPLITUDE MODULATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSIMMUNE POLYNEUROPATHY; ELECTROPHYSIOLOGY; FOLLOW UP; GUILLAIN BARRE SYNDROME; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; NERVE BLOCK; NERVE FIBER DEGENERATION; NERVE POTENTIAL; POLYNEUROPATHY; PROGNOSIS; SCORING SYSTEM; SENSORY NERVE;

CHRONIC DISEASE; ELECTROPHYSIOLOGY; FOLLOW-UP STUDIES; GUILLAIN-BARRE SYNDROME; HUMANS; POLYNEUROPATHIES;

EID: 2542506473     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Léger JM, Chassande B. - Traitement des neuropathies périphériques dysimmunitaires chroniques. Ann Med Interne, 2000, 151, suppl 1, 1S19-1S23.
2. Van Doorn PA, Garssen MPJ. - Treatment of immune neuropathies. Curr Opin Neurol, 2002, 15, 623-631.
3. Merkies IS, Schmitz PI, Van der Méché FG, et al. - Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry, 2002, 72, 596-601.
4. Feasby TE, Brown WF, Gilbert JJ, et al. - The pathological basis of a conduction block in human neuropathies. J Neurol Neurosurg Psychiatry, 1985, 48, 239-244.
5. Brown WF, Feasby TE. - Conduction block and denervation in Guillain-Barre polyneuropathy. Brain, 1984, 107, 219-239.
6. Clouston PD, Kiers L, Zuniga, et al. - Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol, 1994, 93, 245-254.
7. Gordon PH, Wilbourn AJ. - Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol, 2001, 58, 913-917.
8. Ropper AH, Wijdicks EFM, Shahani BT. - Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barre syndrome. Arch Neurol, 1990, 47, 881-887.
9. Hadden RDM, Cornblath DR, Hughes RAC, et al. - Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Ann Neurol, 1998, 44, 780-788.
10. Albers JW, Donofrio PD, McGonagle TK. - Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 1985, 8, 528-539.
11. Albers JW, Kelly JJ. - Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve, 1989, 12, 435-451.
12. Meulstee J, Van der Méché FGA and the Dutch Guillain-Barré Study Group. - Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry, 1995, 59, 482-486.
13. Cornblath DR, Mellits DE, Griffin JW, et al. - Motor conduction studies in Guillain-Barre syndrome: description and pronostic value. Ann Neurol, 1988, 23, 354-359.
14. Triggs WJ, Cros D, Gominak SC, et al. - Motor nerve inexcitability in Guillain-Barre syndrome. The spectrum of distal conduction block and axonal degeneration. Brain, 1992, 115, 1291-1302.
15. McLeod JG, Walsh JC, Prineas JW, et al. - Acute idiopathic polyneuritis. A clinical and electrophysiological follow-up study. J Neurol Sci, 1976, 27, 145-162.
16. Maisonobe T, Léger JM. - Polyradiculonévrites chroniques. Encycl Méd Chir (Elsevier, Paris), Neurologie, 17-095-A-30, 1-8.
17. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. - Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology, 1991, 41, 617-618.
18. Bromberg MB. - Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve, 1991, 14, 968-976.
19. Maisonobe T, Chassande B, Vérin M, et al. - Chronic dysimmune demyelinating polyneuropathy: a clinical, electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry, 1996, 61, 36-42.
20. Briani C, Brannagan TH III, Trojaborg W, et al. - Chronic inflammatory demyelinating polyneuropathy. Neuromusc Disord, 1996, 6, 311-325.
21. Trojaborg W. - Acute and chronic neuropathies: new aspects of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: an overview and an update. Electroencephalogr Clin Neurophysiol, 1998, 107, 303-316.
22. nd ed. Royal Society of Medicine Press: London, 1997, 53-59.
23. Hughes R, Bensa S, Willison H, et al. - Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyneuropathy. Ann Neurol, 2001, 50, 195-201.
24. Nicolas G, Maisonobe T, Le Forestier N, et al. - Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 2002, 25, 26-30.
25. Kaku DA, England JD, Sumner AJ. - Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated-glycoprotein and sulphated glucuronyl paragloboside. Brain, 1994, 117, 941-947.
26. Steck AJ, Kuntzer T. - Polyradiculonévrites inflammatoires chroniques. In: Bouche P, Vallat JM (Eds). Neuropathies périphé riques: polyneuropathies et mononeuropathies multiples. Doin. Paris, 1992, 504-538.
27. Bromberg MB, Albers JW. - Pattern of sensory nerve conduction abnormalities in demyelinating and axonal nerve disorders. Muscle Nerve, 1993, 16, 262-266.
28. Vallat JM, Tabaraud F, Magy L, et al. - Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of 8 cases. Muscle Nerve, 2003, 27, 478-485.
29. Oh SJ. - Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch Neurol, 1978, 35, 509-516.
30. Barohn RJ, Kissel JT, Warnolts JR, et al. - Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol, 1989, 46, 878-884.
31. Kiers L, Clouston P, Zuniga G, et al. - Quantitative studies of F responses in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol, 1994, 93, 255-264.
32. Simmons Z, Albers JW, Bromberg MB, et al. - Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain, 1995, 118, 359-368.
33. Katz JS, Saperstein DS, Gronseth G, et al. - Distal acquired demyelinating symmetric neuropathy. Neurology, 2000, 54, 615-620.
34. Hughes RAC. - Systemic review of treatment for chronic inflammatory demyelinating neuropathy. Rev Neurol, 2002, 158, 12, 6S35-6S40.
35. Ropper AH. - Current treatments for CIDP. Neurology, 2003, 60 (Suppl 3), S16-S22.
36. Hahn AF, Bolton CF, Pillay N, et al. - Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain, 1996, 119, 1055-1066.
37. Hahn AF, Bolton CF, Zochdone D, et al. - Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain, 1996, 119, 1067-1077.
38. Dyck PJ, Daube J, O'Brien PC, et al. - Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med, 1986, 314, 461-465.
39. Dyck PJ, Litchy WJ, Kratz KM, et al. - A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyneuropathy. Ann Neurol, 1994, 36, 838-845.
40. Dyck PJ, O'Brien PC, Oviatt KF, et al. - Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol, 1982, 11, 136-141.
41. Hadden RDM, Sharrack B, Bensa S, et al. - Randomized trial of interferon bêta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology, 1999, 53, 57-71.
42. Mendell JR, Barohn RJ, Freimer ML, et al. - Randomized controlled trial of IgIV in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology, 2001, 56, 445-449.
43. Gorson KC, Ropper AH, Clark BD, et al. - Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology, 1998, 50, 84-87.
44. Vallat JM, Hahn AF, Léger JM, et al. - Interferon bêta-1a as an investigational treatment for CIDP. Neurology, 2003; 60 (Suppl 3), S23-S28.
45. Lewis RA, Sumner AJ, Brown MJ, et al. - Multifocal demyelinating neuropathy with persistent conduction block. Neurology, 1982, 32, 958-964.
46. Viala K, Renié L, Maisonobe T, et al. - Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain, 2004, submitted.
47. Roth G, Magistris MR, Ochsner F. - Motor neuropathy with proximal multifocal persistent block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol, 1986, 25, 416-423.
48. Nobile-Orazio E. - Multifocal motor neuropathy. J Neuroimmunol, 2001, 115, 4-18.
49. Bouche P, Moulonguet A, Ben Younes-Chennoufi A, et al. - Multifocal motor neuropathy associated with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry, 1995, 59, 38-44.
50. Le Forestier N, Chassande B, Moulonguet A, et al. - Neuropathies motrices multifocales avec blocs de conduction: 39 cas. Rev Neurol, 1997, 153, 579-586.
51. ENMC International Workshop. - Multifocal motor neuropathy. 14-15 april 2000, Hilversum, the Netherlands. Neuromusc Disord, 2001, 11, 309-314.
52. Olney RK, Lewis RA, Putnam TD, et al. - Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve, 2003, 27, 117-121.
53. Taylor BV, Wright RA, Harper CM, et al. - Natural history of 46 patients with multifocal motor neuropathy with conduction block. Neurology, 2000, 23, 900-908.
54. Léger JM, Gruwez B, Chassande B, et al. - Long-term treatment of multifocal motor neuropathy with persistent conduction blocks: a retrospective study of 43 cases. Neurology, 2000, 54 (suppl 3):A213.
55. Federico P, Zochodne DW, Hahn AF, et al. - Multifocal motor neuropathy improved by IgIV. Randomized, double-blind, placebo-controlled, study. Neurology, 2000, 55, 1256-1262.
56. Léger JM, Chassande B, Musset L, et al. - Intravenous immunoglobulin in the treatment of multifocal motor neuropathy with persistent conduction blocks: a randomized, double-blind, placebo-controlled study of 19 patients. Brain, 2001, 124, 145-153.
57. Van den Berg-Vos RM, Franssen H, Wokke HJ, et al. - Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol, 2000, 48, 919-926.
58. Van den Berg-Vos RM, Franssen H, Wokke HJ, et al. - Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain, 2002, 125, 1875-1886.
59. Van den Berg-Vos RM, Franssen H, Visser J, et al. - Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment. J Neurol, 2002, 249, 330-336.
60. Magy L, Chassande B, Maisonobe T, et al. - Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol, 2003, 10, 677-685.
61. Nobile-Orazio E, Carpo M. - Neuropathy and monoclonal gammopathy. Curr Opin Neurol, 2001, 14, 615-620.
62. Chassande B, Léger JM, Ben Younes-Chennoufi A, et al. - Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve, 1998, 21, 55-62.
63. Kyle RA, Therneau TM, Rajkumar SV, et al. - A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med, 2002, 346, 564-569.
64. Nobile-Orazio E, Meucci N, Baldini L, et al. - Long-term treatment of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain, 2000, 123, 710-717.
65. Smith IS. - The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain, 1994, 117, 949-957.
66. Oksenhendler E, Chevret S, Léger JM, et al. - Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry, 1995, 59, 243-247.
67. Wilson HC, Lunn MPT, Schey S, et al. - Successful treatment of IgM paraproteinaemic neuropathy with fludarbine. J Neurol Neurosurg Psychiatry, 1999, 66, 575-580.
68. Renaud S, Gregor M, Fuhr P et al. - Rituximab in the treatment of anti-MAG associated polyneuropathy. Muscle Nerve, 2003, 27, 611-615.